Biotech

All Articles

Daiichi spends Merck $170M to create bronchi cancer cells T-cell engager contract

.Merck &amp Co. has swiftly made back several of the expenses of its own Javelin Therapies buyout, p...

BioMarin standstills preclinical gene treatment for heart disease

.After BioMarin performed a springtime well-maintained of its pipeline in April, the business has ac...

Eisai plants molecular adhesive SEED with $1.5 B biobucks handle

.Large Pharmas continue to be caught to the concept of molecular adhesive degraders. The current pro...

Life scientific research credit score agency introduces along with $600M

.A new global life science credit score organization, nicknamed Symbiotic Resources, has actually in...

BMS channels TIGIT, bowing out $200M bank on Agenus bispecific

.Bristol Myers Squibb is actually axing one more major wager coming from the Caforio time, terminati...

Nuvation halts BET prevention after taking into consideration stage 1 data

.After taking a look at period 1 information, Nuvation Biography has chosen to halt work with its on...

' Medical instinct' led FDA experts to support Zevra's uncommon condition med

.Zevra Therapies' unusual ailment medication seems to be to be on the path to confirmation this fall...

Pfizer takes $230M attacked after axing fell short DMD gene treatment

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) gene therapy failing has blown a $230 thousand hol...

AC Immune views 'site' possible in Alzheimer's medication information

.After much more than two decades of deal with neurodegenerative health conditions, Swiss biotech AC...

GSK goes down ph. 2 HPV vaccine over lack of best-in-class prospective

.GSK has ditched a stage 2 human papillomavirus (HPV) vaccine from its own pipe after making a decis...